We are live on ! Find out more
SIC

Starr International Company Portfolio holdings

AUM $19.9M
1-Year Est. Return 39.69%
This Fund
S&P 500
This Quarter Est. Return
+62.96%
1 Year Est. Return
-39.69%
3 Year Est. Return
-26.08%
5 Year Est. Return
-43.79%
10 Year Est. Return
-39.24%
AUM
$149M
AUM Growth
+$89.4M
Cap. Flow
+$39.7M
Cap. Flow %
26.6%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
2
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
CELU icon
Celularity
CELU
+$39.8M
2
BCSF icon
Bain Capital Specialty
BCSF
+$148K

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$225K

Sector Composition

Rank Sector Weight
1 Healthcare 89.13%
2 Financials 10.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELU icon
1
Celularity
CELU
$22M
$133M 89.13%
1,528,139
+664,069
+77% +$39.8M
BCSF icon
2
Bain Capital Specialty
BCSF
$833M
$12.5M 8.39%
803,899
+9,356
+1% +$148K
AIG icon
3
American International
AIG
$42.9B
$3.71M 2.48%
59,040
-3,748
-6% -$225K

Similar funds

DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return

Starr International Company's Q1 2022 Portfolio in Review

As of Q1 2022, Starr International Company held 3 positions worth $149M, up 149% from $59.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Starr International Company deployed $39.7M of net new capital in Q1 2022, adding to 2 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 74% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was American International, an estimated $225K trimmed.

  • Starr International Company added most to Celularity in Q1 2022, an estimated $39.8M increase.
  • Starr International Company's biggest Q1 2022 reduction was American International, cutting an estimated $225K.
  • Starr International Company's ten largest holdings make up 100% of its $149M portfolio in Q1 2022.
  • Starr International Company opened 0 new positions and closed 0 in Q1 2022.
  • Starr International Company's portfolio value rose 149% quarter-over-quarter to $149M.

Based on Starr International Company's 13F filing for Q1 2022, filed 11 May 2022.